David Rodriguez-Luna1, Matthew Boyko1, Suresh Subramaniam1, Evgenia Klourfeld1, Patricia Jo1, Brendan J Diederichs1, Jayme C Kosior1, Dar Dowlatshahi1, Richard I Aviv1, Carlos A Molina1, Michael D Hill1, Andrew M Demchuk2. 1. From the Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital and Vall d'Hebron Research Institute, Barcelona, Spain (D.R.-L., C.A.M.); Calgary Stroke Program, Department of Clinical Neurosciences and Radiology, University of Calgary, Calgary, AB, Canada (D.R.-L., M.B., S.S., E.K., P.J., B.J.D., M.D.H., A.M.D.); Cybertrial Medical Software Inc, Edmonton, Canada (J.C.K.); Department of Medicine, Neurology, The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada (D.D.); and Division of Neuroradiology and Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada (R.I.A.). 2. From the Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital and Vall d'Hebron Research Institute, Barcelona, Spain (D.R.-L., C.A.M.); Calgary Stroke Program, Department of Clinical Neurosciences and Radiology, University of Calgary, Calgary, AB, Canada (D.R.-L., M.B., S.S., E.K., P.J., B.J.D., M.D.H., A.M.D.); Cybertrial Medical Software Inc, Edmonton, Canada (J.C.K.); Department of Medicine, Neurology, The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada (D.D.); and Division of Neuroradiology and Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada (R.I.A.). ademchuk@ucalgary.ca.
Abstract
BACKGROUND AND PURPOSE: Limiting intracerebral hemorrhage (ICH) and intraventricular hemorrhage (IVH) expansion is a common target for acute ICH studies and, therefore, accurate measurement of hematoma volumes is required. We investigated the amount of hematoma volume difference between computed tomography scans that can be considered as measurement error. METHODS: Five raters performed baseline (<6 hours) and 24-hour total hematoma (ICH+IVH) computer-assisted volumetric analysis from 40 selected ICH patients from the Predicting Hematoma Growth and Outcome in Intracerebral Hemorrhage Using Contrast Bolus CT (PREDICT) study cohort twice. Estimates of intrarater and interrater reliability are expressed as intraclass correlation coefficients and minimum detectable difference (MDD). RESULTS: Total hematoma volumetric analyses had excellent intra- and interrater agreements (intraclass correlation coefficients 0.994 and 0.992, respectively). MDD for intra- and interrater volumes was 6.68 and 7.72 mL, respectively, and were higher the larger total hematoma volume was and in patients with subarachnoid hemorrhage or IVH. MDD for total hematoma volume measurement of 10.4 mL was found in patients with largest hematoma volumes. In patients with subarachnoid hemorrhage or IVH, MDD for total hematoma volume was 10.3 and 10.4 mL, respectively. In patients without IVH, MDD for intra- and interrater pure ICH volumes were 3.82 and 5.83 mL, respectively. CONCLUSIONS: A threshold higher than 10.4 mL seems to be reliable to avoid error of total hematoma volume measurement in a broad range of patients. An absolute ICH volume increase of >6 mL, commonly used as outcome in ICH studies, seems well above MDD and, therefore, could be used to reliably detect ICH expansion.
BACKGROUND AND PURPOSE: Limiting intracerebral hemorrhage (ICH) and intraventricular hemorrhage (IVH) expansion is a common target for acute ICH studies and, therefore, accurate measurement of hematoma volumes is required. We investigated the amount of hematoma volume difference between computed tomography scans that can be considered as measurement error. METHODS: Five raters performed baseline (<6 hours) and 24-hour total hematoma (ICH+IVH) computer-assisted volumetric analysis from 40 selected ICHpatients from the Predicting Hematoma Growth and Outcome in Intracerebral Hemorrhage Using Contrast Bolus CT (PREDICT) study cohort twice. Estimates of intrarater and interrater reliability are expressed as intraclass correlation coefficients and minimum detectable difference (MDD). RESULTS: Total hematoma volumetric analyses had excellent intra- and interrater agreements (intraclass correlation coefficients 0.994 and 0.992, respectively). MDD for intra- and interrater volumes was 6.68 and 7.72 mL, respectively, and were higher the larger total hematoma volume was and in patients with subarachnoid hemorrhage or IVH. MDD for total hematoma volume measurement of 10.4 mL was found in patients with largest hematoma volumes. In patients with subarachnoid hemorrhage or IVH, MDD for total hematoma volume was 10.3 and 10.4 mL, respectively. In patients without IVH, MDD for intra- and interrater pure ICH volumes were 3.82 and 5.83 mL, respectively. CONCLUSIONS: A threshold higher than 10.4 mL seems to be reliable to avoid error of total hematoma volume measurement in a broad range of patients. An absolute ICH volume increase of >6 mL, commonly used as outcome in ICH studies, seems well above MDD and, therefore, could be used to reliably detect ICH expansion.
Authors: Sandro Marini; William J Devan; Farid Radmanesh; Laura Miyares; Timothy Poterba; Björn M Hansen; Bo Norrving; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano; Jaume Roquer; Christina E Kourkoulis; Alison M Ayres; Kristin Schwab; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Joan Montaner; Israel Fernandez-Cadenas; Pilar Delgado; Steven M Greenberg; Arne Lindgren; Charles Matouk; Kevin N Sheth; Daniel Woo; Christopher D Anderson; Jonathan Rosand; Guido J Falcone Journal: Stroke Date: 2018-06-18 Impact factor: 7.914
Authors: Martina B Goeldlin; Bernhard M Siepen; Madlaine Mueller; Bastian Volbers; Werner Z'Graggen; David Bervini; Andreas Raabe; Nikola Sprigg; Urs Fischer; David J Seiffge Journal: Eur Stroke J Date: 2021-11-16
Authors: Eli Gibson; Bogdan Georgescu; Pascal Ceccaldi; Pierre-Hugo Trigan; Youngjin Yoo; Jyotipriya Das; Thomas J Re; Vishwanath Rs; Abishek Balachandran; Eva Eibenberger; Andrei Chekkoury; Barbara Brehm; Uttam K Bodanapally; Savvas Nicolaou; Pina C Sanelli; Thomas J Schroeppel; Thomas Flohr; Dorin Comaniciu; Yvonne W Lui Journal: Radiol Artif Intell Date: 2022-04-20
Authors: Teddy Y Wu; Oluwaseun Sobowale; Robert Hurford; Gagan Sharma; Søren Christensen; Nawaf Yassi; Turgut Tatlisumak; Patricia M Desmond; Bruce C V Campbell; Stephen M Davis; Adrian R Parry-Jones; Atte Meretoja Journal: Neuroradiology Date: 2016-07-05 Impact factor: 2.804
Authors: Vignan Yogendrakumar; Andrew M Demchuk; Richard I Aviv; David Rodriguez-Luna; Carlos A Molina; Yolanda S Blas; Imanuel Dzialowski; Adam Kobayashi; Jean-Martin Boulanger; Cheemun Lum; Gord Gubitz; Vasantha Padma; Jayanta Roy; Carlos S Kase; Rohit Bhatia; Michael D Hill; Dar Dowlatshahi Journal: Eur Stroke J Date: 2017-06-15
Authors: Betty Chinda; George Medvedev; William Siu; Martin Ester; Ali Arab; Tao Gu; Sylvain Moreno; Ryan C N D'Arcy; Xiaowei Song Journal: BMJ Open Date: 2018-04-19 Impact factor: 2.692
Authors: Pascal Salazar; Mario Di Napoli; Mostafa Jafari; Alibay Jafarli; Wendy Ziai; Alexander Petersen; Stephan A Mayer; Eric M Bershad; Rahul Damani; Afshin A Divani Journal: Neurocrit Care Date: 2020-04 Impact factor: 3.210
Authors: David J Seiffge; Martina B Goeldlin; Turgut Tatlisumak; Philippe Lyrer; Urs Fischer; Stefan T Engelter; David J Werring Journal: J Neurol Date: 2019-09-20 Impact factor: 4.849